Cargando…

Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wang, Jinhuan, Miao, Zhaoyi, Jiang, Yanan, Zou, Ping, Li, Weiming, Tang, Xiaoqiong, Lv, Yangyang, Xing, Donghui, Chen, Shi, Yang, Fengchun, Xu, Mingjiang, Cao, Zeng, Wang, Haitao, Zhao, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412723/ https://www.ncbi.nlm.nih.gov/pubmed/32802163 http://dx.doi.org/10.3892/ol.2020.11907

Ejemplares similares

Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
por: Wang, Jinhuan, et al.
Publicado: (2020)

TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2(−/−)-Driven Myeloid Malignancy Progression
por: Li, Rong, et al.
Publicado: (2017)

Corrigendum to “Myeloid FBW7 deficiency disrupts redox homeostasis and aggravates dietary-induced insulin resistance” [Redox Biol. 37 (2020) 101688]
por: Wang, Cheng, et al.
Publicado: (2023)

Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells [Corrigendum]
Publicado: (2021)

The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells
por: Zhao, Zhigang, et al.
Publicado: (2016)

Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
por: D'Angelo, S. P., et al.
Publicado: (2015)

Corrigendum to: Corrosion behavior and cytocompatibility of fluoride-incorporated plasma electrolytic oxidation coating on biodegradable AZ31 alloy
por: Tian, Peng, et al.
Publicado: (2020)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
Publicado: (2016)

Corrigendum to “the long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia” [EBioMedicine 35 (2018) 61–75]
por: Li, Zi-ye, et al.
Publicado: (2018)

Integrated transcriptomic and epigenetic data analysis identifies aberrant expression of genes in acute myeloid leukemia with MLL-AF9 translocation
por: Wang, Fangce, et al.
Publicado: (2021)

Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC)
por: Chu, Yajing, et al.
Publicado: (2018)

Corrigendum to ‘Silencing KIF18B enhances radiosensitivity: Identification of a promising therapeutic target in sarcoma’ [EBioMedicine 61 (2020) 103,056]
por: Liu, Wensi, et al.
Publicado: (2021)

Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”
por: Wu, Dacheng, et al.
Publicado: (2018)

Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency
por: Costa, Yael, et al.
Publicado: (2013)

Corrigendum to “Low-Grade Endometrial Stromal Sarcoma with a Nodule-in-Nodule Appearance in Preoperative Magnetic Resonance Images”
por: Nakamura, Mitsuhiro, et al.
Publicado: (2021)

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
por: Yamada, Hideharu, et al.
Publicado: (2021)

Corrigendum to “FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice”
por: Zhang, Rui, et al.
Publicado: (2020)

Diagnostic radiography and adult acute myeloid leukemia: an interview and medical chart review study
por: Pogoda, J M, et al.
Publicado: (2012)

Corrigendum to “An Unusual Cause of Bleeding in a Patient with Chronic Myeloid Leukemia Chronic Phase”
por: Kartthik, S., et al.
Publicado: (2020)

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
por: Guan, Yihong, et al.
Publicado: (2020)

Polη, Polζ and Rev1 together are required for G to T transversion mutations induced by the (+)- and (−)-trans-anti-BPDE-N(2)-dG DNA adducts in yeast cells
por: Zhao, Bo, et al.
Publicado: (2006)

Corrigendum to “Cholesterol confers ferroptosis resistance onto myeloid-biased hematopoietic stem cells and prevents irradiation-induced myelosuppression” [Redox Biol. 62 (2023) 102661]
por: Liu, Chaonan, et al.
Publicado: (2023)

Corrigendum to “Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Shikonin Treatment of CIA by Regulating Treg/Th17 Expression”
por: Dai, Qiaomei, et al.
Publicado: (2019)

Corrigendum to “Metabolic Syndrome, Inflammation, and Cancer”
por: Wu, Yong, et al.
Publicado: (2017)

The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution [Corrigendum]
Publicado: (2019)

The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum]
Publicado: (2020)

Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9
por: Ye, Conglin, et al.
Publicado: (2021)

Construction of the plasmid for expression of EGFP-M-IL-2(88Arg, 125Ala) fusion protein and the anti-tumor effects exerted by the fusion protein in HeLa-60 cells
por: Shao, Guangcan, et al.
Publicado: (2021)

New developments in the management of congenital Factor XIII deficiency [Corrigendum]
Publicado: (2013)

Relative nutritional deficiencies associated with centrally acting monoamines [Corrigendum]
Publicado: (2015)

Corrigendum to “Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders” [Redox Biology 32, 2020, 101535]
por: Zhang, Xin, et al.
Publicado: (2021)

Corrigendum to: Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex
por: Rao, Jianhua, et al.
Publicado: (2021)

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
por: Cummins, K D, et al.
Publicado: (2014)

[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling
por: Liu, Yan-Hong, et al.
Publicado: (2023)

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
por: Nabil, Reem, et al.
Publicado: (2022)

miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
por: Ye, Conglin, et al.
Publicado: (2021)

Corrigendum to “First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children” [Mol. Genet. Metab. Rep. 2 (2016) 81–84]
por: Senanayake, Danika Nadeen, et al.
Publicado: (2016)

Tet1 Deficiency Leads to Premature Ovarian Failure
por: Liu, Linlin, et al.
Publicado: (2021)

Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency [Corrigendum]
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qrksjkj4mqg3ru5vk2tr2akgr6